§ Funding Round
Series B funding round for ImCheck Therapeutics raising $53M in December 2019
Series B funding round for ImCheck Therapeutics raising $53M in December 2019
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
EQT Life Sciences | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
SR One | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Boehringer Ingelheim | — | — |
thibaut roulonLEAD | Angel | thibaut roulon |
| Angel | bram vanparys, phd, mba | |
| Organization | — | |
| Angel | vincent brichard |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$182M
Top Valuation
-
ImCheck Therapeutics raised $53M in a Series B round.
The round was announced on 12/01/19.
The round was led by thibaut roulon.
